Cocrystal Pharma, Inc. (COCP)
NASDAQ: COCP · Real-Time Price · USD
1.540
-0.026 (-1.69%)
Aug 25, 2025, 4:00 PM - Market closed

Cocrystal Pharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
Net Income
-12.56-17.5-17.98-38.84-14.19-9.65
Upgrade
Depreciation & Amortization
0.080.130.190.190.380.34
Upgrade
Asset Writedown & Restructuring Costs
---19.09--
Upgrade
Stock-Based Compensation
0.50.640.80.860.720.66
Upgrade
Other Operating Activities
0.040.11-0.01-0.02-0.24-0.12
Upgrade
Change in Accounts Receivable
----0.560.09
Upgrade
Change in Accounts Payable
-0.89-0.92.05-0.320.22-0.92
Upgrade
Change in Other Net Operating Assets
0.021.360.47-1.68-0.17-0.23
Upgrade
Operating Cash Flow
-13.38-16.49-14.67-21.44-12.72-9.83
Upgrade
Capital Expenditures
--0.01-0.12-0.07-0.05-0.24
Upgrade
Investing Cash Flow
--0.01-0.12-0.07-0.05-0.24
Upgrade
Long-Term Debt Repaid
---0.01-0.03-0.04-0.12
Upgrade
Net Debt Issued (Repaid)
---0.01-0.03-0.04-0.12
Upgrade
Issuance of Common Stock
--4-38.5135.78
Upgrade
Financing Cash Flow
--3.99-0.0338.4735.66
Upgrade
Net Cash Flow
-13.38-16.49-10.79-21.5425.725.59
Upgrade
Free Cash Flow
-13.38-16.49-14.78-21.51-12.77-10.07
Upgrade
Free Cash Flow Margin
------500.00%
Upgrade
Free Cash Flow Per Share
-1.31-1.62-1.53-2.64-1.73-2.19
Upgrade
Levered Free Cash Flow
-8.74-10.29-10.01-13.12-7.28-6.25
Upgrade
Unlevered Free Cash Flow
-8.74-10.29-10.01-13.12-7.28-6.24
Upgrade
Change in Working Capital
-1.430.142.34-2.710.6-1.06
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q